Medicare Enrolled

Dr. Raj Karunakara, M.D.

Pulmonary Disease · Ocala, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1834 SW 1ST AVE, Ocala, FL 34474
3527325552
In practice since 2006 (19 years)
NPI: 1114980067 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Karunakara from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Karunakara? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Karunakara

Dr. Raj Karunakara is a pulmonary disease in Ocala, FL, with 19 years in practice. Based on federal Medicare data, Dr. Karunakara performed 2,392 Medicare services across 1,863 unique beneficiaries.

Between the years covered by Open Payments, Dr. Karunakara received a total of $16,085 from 50 pharmaceutical and/or device companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Karunakara is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 26% volume in FL$ $16,085 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,392
Medicare services
Top 26% in FL for pulmonary disease
1,863
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~126 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity467$96$180
Office visit, established patient (30-39 min)319$99$190
Initial hospital admission, high complexity189$140$263
Critical care, first 30-74 min162$174$326
Office visit, established patient (20-29 min)138$65$137
Test to measure expiratory airflow and volume changes before and after medication administration107$30$88
Test to examine how well the lungs exchange gases101$43$67
Test to determine lung volumes using sensors96$41$65
Artery puncture collection of blood sample82$22$40
Carboxyhemoglobin (protein) level82$12$25
Blood gases measurement, with o2 saturation82$77$90
Methemoglobin (hemoglobin) analysis, quantitative82$8$9
Blood potassium level82$5$8
Blood sodium level82$5$8
Blood count, hemoglobin82$2$5
New patient office visit (45-59 min)78$123$250
Office visit, established patient, complex (40-54 min)45$143$268
New patient office visit, complex (60-74 min)24$177$330
Test for exercise-induced lung stress22$26$60
Chest X-ray, 2 views19$25$55
Sleep study in sleep lab (6 years or older)16$460$1,000
Irrigation and suction of lung airways to obtain cells using an endoscope12$28$340
Sleep study in sleep lab with continuous airway pressure (6 years or older)12$473$1,200
Test for exercise-induced heart and lung stress11$99$185
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,085
Total received (2018-2024)
Avg $2,298/year across 7 years
Top 13% in FL for pulmonary disease
50
Companies
391
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,992 (74.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,094 (25.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,416
2023
$1,217
2022
$6,958
2021
$2,304
2020
$1,059
2019
$1,694
2018
$1,436

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$3,835
GlaxoSmithKline, LLC.
$2,597
Ethicon Inc.
$2,023
Boehringer Ingelheim Pharmaceuticals, Inc.
$987
AstraZeneca Pharmaceuticals LP
$872
United Therapeutics Corporation
$693
GENZYME CORPORATION
$524
Grifols USA, LLC
$459
Bayer HealthCare Pharmaceuticals Inc.
$335
Janssen Pharmaceuticals, Inc
$319
ABIOMED
$300
Actelion Pharmaceuticals US, Inc.
$285
Regeneron Healthcare Solutions, Inc.
$279
Genentech USA, Inc.
$233
Inari Medical, Inc.
$230
Philips Electronics North America Corporation
$212
INTUITIVE SURGICAL, INC.
$184
Pulmonx Corporation
$135
Medical Device Business Services, Inc.
$127
Stryker Corporation
$125
E.R. Squibb & Sons, L.L.C.
$121
Takeda Pharmaceuticals U.S.A., Inc.
$111
PORTOLA PHARMACEUTICALS, INC.
$98
Bayer Healthcare Pharmaceuticals Inc.
$93
Electromed, Inc.
$82
JAZZ PHARMACEUTICALS INC.
$75
ZOLL Respicardia, Inc.
$73
Inogen, Inc.
$66
Sunovion Pharmaceuticals Inc.
$62
Amgen Inc.
$61
Mylan Specialty L.P.
$54
Insmed, Inc.
$53
Tactile Systems Technology Inc
$33
Harmony Biosciences LLC
$33
Mallinckrodt Hospital Products Inc.
$33
Merck Sharp & Dohme LLC
$33
PFIZER INC.
$27
SOBI, INC
$25
ALK-Abello, Inc
$24
Avadel CNS Pharmaceuticals, LLC
$22
Covis Pharma GmBH
$20
Harmony Biosciences Llc
$20
Hikma Pharmaceuticals USA
$17
La Jolla Pharmaceutical Company
$16
Allergan Inc.
$16
Penumbra, Inc.
$16
Boston Scientific Corporation
$15
Nabriva Therapeutics, plc
$12
Breathe Technologies, Inc.
$11
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$11
Top 3 companies account for 52.6% of total payments
Associated products mentioned in payments ›
(2809) Trilogy 100 · (8874) inCourage · ACTHAR · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · DUPIXENT · Da Vinci Surgical System · EXALT Model D · Esbriet · FASENRA · FLOWTRIEVER CATHETER · Flexitouch Plus · GIAPREZA · GLASSIA · IMFINZI · ION · Impella · Indigo System · InogenOne · LIFE2000 · LONHALA MAGNAIR · LUMRYZ · LifeVest · MAKO · Monarch Platform · NONE · NUCALA · OFEV · OPDIVO · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Odactra · Prolastin-C · Prolastin-C Liquid · Ryaltris · S · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYNAGIS · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · WAKIX · XARELTO · XYWAV · Xenleta · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $672 per 100 Medicare services performed
Looking for a pulmonary disease in Ocala?
Compare pulmonary diseases in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
8
Per 100K population
2.1
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Karunakara is a clinical cardiology specialist, with above-average Medicare volume (top 26% in FL), and high industry engagement (low-engagement, top 13%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Karunakara experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Karunakara performed 467 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Karunakara receive payments from pharmaceutical companies?
Yes. Dr. Karunakara received a total of $16,085 from 50 companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Karunakara's costs compare to other pulmonary diseases in Ocala?
Dr. Karunakara's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Karunakara) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →